+ Watch MSNWQ
on My Watchlist
The Company is a healthcare staffing company and is a provider of per diem nurse staffing services.
History has proven that, especially within the temporary healthcare staffing marketplace, mergers rarely work out favorably for the company or the investor. Sadly, this fate will negatively impact MRN's stock price for a long time to come.MRN lacks any real quality in their senior leadership to overcome their history. The stock has traditionally underperformed anyway. In a desperate attempt to regain some aire of significance in the temporary healthcare marketplace, they resorted to their desperate strategy of buying their way to the top.MSN grew early on through the aquisition and consolidation business model. MSN failed even at that time to hold their realized revenue and net income increases. They have closed a number of those mom and pop locations due to a lack of organic growth. Why would any sane investor think their recent HUGE aquisition would be any different? OK. Those that took the MSN bait will make every effort to play up the stock for selfish reasons. However, the neutral investor will see MSN for what it is - a wannabe player in the industry.SELL! SELL! SELL!
UPDATE: MRN shelled out a smooth 90 mil for IntelliStaff - and vastly overpaid! Since their most recent attempt at consilidation, the ROI has been terrible. The cultures of the companies didn't mesh well at all. The IntelliStaff employees are not walking - they are RUNNING for the exits. Revenues will certainly suffer. True, as the population grows older, the shortages for healthcare professionals will become more acute. However, MRN is far from the only game in town. In fact, there are several other companies that have taken significant market share from MSN in the past 12 months. Their senior leadership is incapable of leading this once healthcare darling (IPO'd at $15'ish and would throw a huge party at $6) out of the current morass and the institutional investors have to be very concerned as MRN moves towards a new 52-week low.I told you almost a year ago.... SELL this poor old dog stock!!!
one more pick and you'll be doing good. why did you stop at 6?
They dropped 10 % today and fell to a new 52-week low. The InteliStaff acquisition has been by many accounts a total disaster thus far despite the institutional spin. I hate to say this, but, "I told you so!" The new MRN theme song should "Freefalling" by Tom Petty.
Turn out the lights, the party's over...Medical Staffing Network, "one of the largest healthcare staffing companies," has officially gone down the toilet like the piece of ...junk... stock that it is! Yes, that's right kids. They are being delisted by the NYSE. Hope you took my bearish advice at $6/share!The success or failure of any company starts with its leadership or lack thereof. Enough said.Ciao.
SELL!! get out as soon as possible just like MRN's employees. Dropping like flies accross the country. MSN closed numerous local offices accross the country and for a company that prides itself on "Per diem" and local nurses being the biggest part of their business, they have dropped in every category. When MSN bought Intelistaf for their travelers, they were only around 100 travelers themselves. MSN walked into Intelistaf pushing 1000 travelers on assignment and today, they may be lucky to be sitting at 300 and just lost another big partnership contract. The senior leadership team has no clue what to do and they keep letting employees go and firing others for not performing. Employees here have lost respect for the company and it is in the same boat it was in before they bought out Intelistaf for 90+ million. What a joke. Going from 120+ employees a year ago to under 40 in the travel division is a sign that the travel division is doomed for failure and they can thank senior leadership for that.
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates, Analyst Ratings and Key Statistics provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions